{"url_path":"/sec/cgtx/8-k/2026-06-04/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1455365/0001104659-26-070345-index.html","accession_number":"0001104659-26-070345","cik":"0001455365","ticker":"CGTX","issuer_name":"COGNITION THERAPEUTICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1455365/0001104659-26-070345-index.html","primary_entity_key":"0001455365","primary_entity_name":"COGNITION THERAPEUTICS INC"},"word_count":119,"has_tables":true,"body_markdown":"**Item 7.01 Regulation FD Disclosure.**\n\n \n\nAttached as Exhibit 99.1 and furnished for\npurposes of Regulation FD is a presentation that Cognition Therapeutics, Inc. may use from time to time in presentations or discussions\nwith investors, analysts, and other parties.\n\n \n\nThe information in this Item 7.01 (including\nExhibit 99.1) is being furnished solely to satisfy the requirements of Regulation FD and shall not be deemed to be “filed”\nfor the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject\nto the liabilities of that Section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933,\nas amended, or the Exchange Act."}